Skip to main content
RuszinkoViktoria_Gyermek_gastro

 

Irodalom:
1. Cucchiara S, Latiano A, Palmieri O et al: Polymorphisms of tumor necrosis factor (alpha) but not
MDR1 influence response to medical therapy in pedoatric-onset inflammatory bowel disease. J Pediatr
Gastroenterol Nutr, 2007; 44 : 171-9
2. Hsiao CH, Wei SC, Wong JM et al: Pediatric Crohn disease: clinical and genetic characteristics in Taiwan.
J Pediatr Gastroenterol Nutr, 2007; 44 : 342-6
3. Walker TR, Land ML, Kartashov A et al: Fecal lactoferrin is a sensitive and specific marker of disease
activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr,
2007; 44 : 414-22
4. Castro M, Rossi L, Papadatou B et al: Long-term treatment with autologous red blood cells loaded with
dexamethasone 21-phosphatase in pediatric patients affected by steroid-dependent Crohn disease. J
Pediatr Gastroenterol Nutr, 2007; 44 : 423-6
5. Otake K, Uchida K, Inoue M et al: Successful treatment with topical 5-aminosalicylic acid ointment
and spray of refractory oral and pharyngeal ulcerations in a child with Crohn disease. J Pediatr
Gastroenterol Nutr, 2007; 44 : 378-81
6. Mahgoub L, Puntis J, Chetcuti P: Severe Crohn disease of the lung following colectomy. J Pediatr
Gastroenterol Nutr, 2007; 45 : 477-9
7. Mackey AC, Green L, Liang L et al: Hepatosplenic T cell lymphoma associated with infliximab use in
young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 2007; 44 : 265-7
8. Ravikumara M, HinsbergerA, Spray CH: Role of methotrexate in the management of Crohn disease. J
Pediatr Gastroenterol Nutr, 2007; 44 : 427-30
9. de Ridder L, Benninga MA, Taminiau JA et al: Infliximab use in children and adolescents with inflammatory
bowel disease. J Pediatr Gastroenterol Nutr, 2007; 45 : 3-14
10. Fanjiang G, Russell GH, Katz AJ: Short- and long-term response to and weaning from infliximab therapy
in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr, 2007; 44 : 312-7
11. Hyams JS, Wilson DC, Thomas A et al: Natalizumab therapy for moderate to severe Crohn disease in
adolescents. J Pediatr Gastroenterol Nutr, 2007; 44 : 185-91
12. Moy L, Levine J: Wireless capsule endoscopy in the pediatric age group: experience and complications. J
Pediatr Gastroenterol Nutr, 2007; 44 : 516-20
13. Thomson M, Fritscher-Ravens A, Mylonaki M et al:Wireless capsule endoscopy in children: A study to assess
diagnostic yield in small bowel disease in pediatric patients. J Pediatr Gastroenterol Nutr, 2007;44 : 192-7
14. Shamir R, Hino B, Hartman C et al: Wireless video capsule in pediatric patients with functional abdominal
pain. J Pediatr Gastroenterol Nutr, 2007; 44 : 45-50
15. El-Matary W: Wireless capsule endoscopy: indications, limitations, and future challanges. J Pediatr
Gastroenterol Nutr, 2008; 46 : 4-12
16. Kravarusic D, Feigin E, Dlugy E et al: Colorectal carcinoma in childhood: A retrospective multicenter
study. J Pediatr Gastroenterol Nutr, 2007; 44 : 209-11